Gola Action (Benzydamine Hydrochloride, Cetylpyridinium Chloride)

Gola Action is indicated for the symptomatic relief of several common oral and pharyngeal conditions.

• Sore throat associated with minor inflammation or irritation.
• Oral mucositis occurring during chemotherapy or radiotherapy.
• Minor mouth ulcers such as aphthous lesions.
• Gingivitis and early-stage gum inflammation.
• Post‑dental procedure discomfort.
• Dry mouth discomfort when accompanied by mild inflammation.
• Temporary relief of discomfort after orthodontic appliance adjustment.
• The product is applied directly to the affected area and may be used several times daily, depending on symptom severity.

Local anti‑inflammatory and antiseptic agents may cause mild, transient effects in the oral cavity; serious reactions are uncommon but should be recognized.

Common

• Transient burning or tingling sensation in the mouth.
• Mild taste alteration or metallic aftertaste.
• Temporary dryness of the oral mucosa.
• Slight irritation of the throat.
• Mild numbness or loss of sensation in the treated area.
• Temporary discoloration of the oral mucosa.

Serious

• Allergic reaction presenting as swelling of lips, tongue, or face.
• Persistent ulceration or severe irritation of the oral mucosa.
• Signs of anaphylaxis such as difficulty breathing or hives.
• Severe swelling of the throat that interferes with swallowing.

When using Gola Action, certain precautions help ensure safe and effective use, especially in specific populations or clinical situations.

• Do not swallow large amounts; the product is intended for local oral use only.
• Avoid use in individuals with known hypersensitivity to benzydamine, cetylpyridinium chloride, or related compounds.
• Limit duration of use to the period recommended on the label, typically not exceeding a few days without medical advice.
• Consult a healthcare professional before use in pregnant or breastfeeding women, as safety data are limited.
• Keep out of reach of children; accidental ingestion may cause gastrointestinal irritation.
• Do not use on extensive oral lesions or severe infections without professional guidance.

Gola Action may interact with other oral products or systemic medications; awareness of potential interactions supports safe use.

Avoid

• Concurrent use of other topical oral anesthetics or anti‑inflammatory rinses, which may increase local irritation.
• Use with products containing high concentrations of alcohol or other strong antiseptics, as this can exacerbate mucosal dryness.

Use with caution

• Systemic antihistamines or medications that cause dry mouth, which may enhance the sensation of burning.
• Antibiotic therapy for oral infections, to monitor for additive antiseptic effects.
• Use in patients taking other non‑prescription oral care products; follow dosing intervals to avoid over‑exposure.